
Ivbest 5mg Tablet
Marketer
Mits Healthcare Pvt Ltd
Salt Composition
Ivabradine (5mg)
Overview Ivbest 5mg Tablet
Cardine 5mg tablets effectively manage angina pectoris (chest pain linked to heart issues) and chronic congestive heart failure. It optimizes cardiac function by reducing heart rate, thus alleviating chest discomfort and minimizing hospital readmissions for heart failure patients. Dosage is tailored to the specific condition. As treatment for angina or heart failure is typically ongoing, discontinuation requires physician consultation. Consistent daily ingestion with food is recommended. Overdosage may cause pronounced bradycardia, fatigue, and shortness of breath; seek immediate medical assistance if this occurs. Common, usually transient, adverse effects include visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. Serious reactions like syncope and significant cardiac rhythm changes necessitate urgent medical attention. Refrain from driving until the drug's effects are understood. Contraindicated in patients with severe hepatic impairment, bradycardia, arrhythmias, severely compromised blood pressure, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or lactation.
Primary Ingredients of Ivbest 5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Ivbest 5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivbest 5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 5mg Ivbest tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
Common Side effects of Ivbest 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivbest 5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 5mg Ivbest tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Ivbest 5mg Tablet works:
Cardioslow 5mg tablets decrease cardiac rate, thereby reducing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Ivbest 5mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ivbest 5mg Tablets during pregnancy carries a substantial risk. Pregnant women should consult their physician immediately, as research in both animals and pregnant humans indicates considerable harm to the unborn child.
Breast feedingUNSAFE
Lactation and the use of Ivbest 5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivbest 5mg Tablet, a medication that can induce transient visual disturbances, primarily phosphenes. Night driving should be approached with caution due to the potential for these light flashes.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Ivbest 5mg tablets. Dosage modification may be necessary. A physician's consultation is recommended. Data on Ivbest 5mg tablet use in patients with severe kidney disease is limited.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Ivbest 5mg tablets, as dose modification may be necessary. Severe hepatic dysfunction contraindicates the use of Ivbest 5mg tablets; physician consultation is advised.
What if you forget to take Ivbest 5mg Tablet :
Omit any missed Ivbest 5mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ivbest 5mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Sodium channel blockers targeting the sinoatrial node |
